Other groups have also demonstrated a synergistic effect of simultaneously blocking AURKA and PLK-1 in preliminary studies in diffuse midline glioma [77], paving the way for this promising combinatorial strategy to be translated into clinical trials. Here, PLK1 is linked to diffuse midline glioma.